Bifidobacterium infantis-mediated HSV-TK/GCV therapy modulates the tumor microenvironment through site-specific phosphorylation of HIF-1α, mTOR, and PD-L1 - Top-Institutions - MDSpire

Bifidobacterium infantis-mediated HSV-TK/GCV therapy modulates the tumor microenvironment through site-specific phosphorylation of HIF-1α, mTOR, and PD-L1

By
Jiaming He
Yang Yuan
Jing Li
Yongping Ma
Dilong Chen
June 22, 2026
0 min

Frontiers In Oncology

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

Laboratory Animal Center of Chongqing Medical University

Chongqing, Chongqing
Key Differentiators
- Oncology
#2

Chinese Academy of Sciences

Beijing, Beijing
Key Differentiators
- Oncology
#3

Dana-Farber Cancer Institute

Boston, Massachusetts
Key Differentiators
- Oncology
#4

Mass General Brigham Cancer Institute

Boston, Massachusetts
Key Differentiators
- Oncology
#5

Rutgers Cancer Institute of New Jersey

New Brunswick, New Jersey
Key Differentiators
- Oncology